Legal & General Group Plc bought a new position in shares of Merck KGaA (OTCMKTS:MKGAF – Free Report) during the second quarter, HoldingsChannel.com reports. The institutional investor bought 18,873,343 shares of the company’s stock, valued at approximately $2,425,225,000. Merck KGaA comprises about 0.5% of Legal & General Group Plc’s investment portfolio, making the stock its 29th biggest position. Legal & General Group Plc owned 0.15% of Merck KGaA as of its most recent SEC filing.
Other institutional investors have also modified their holdings of the company. Barrow Hanley Mewhinney & Strauss LLC purchased a new position in Merck KGaA in the second quarter valued at about $942,087,000. Bank of Nova Scotia purchased a new stake in Merck KGaA during the 2nd quarter worth approximately $281,696,000. Danske Bank A S purchased a new stake in Merck KGaA during the 2nd quarter worth approximately $276,535,000. The Manufacturers Life Insurance Company acquired a new position in shares of Merck KGaA in the 2nd quarter valued at approximately $266,403,000. Finally, Cullen Capital Management LLC purchased a new position in shares of Merck KGaA during the 2nd quarter valued at approximately $259,158,000. Institutional investors and hedge funds own 0.10% of the company’s stock.
Merck KGaA Stock Up 0.1%
MKGAF stock opened at $163.45 on Tuesday. Merck KGaA has a twelve month low of $116.68 and a twelve month high of $175.56. The company has a current ratio of 1.31, a quick ratio of 0.84 and a debt-to-equity ratio of 0.27. The company has a market capitalization of $21.12 billion, a P/E ratio of 24.95 and a beta of 0.96. The firm has a 50 day simple moving average of $162.78 and a 200-day simple moving average of $148.59.
Merck KGaA Company Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Featured Articles
- Five stocks we like better than Merck KGaA
- Visa Just Put Hims & Hers in the Penalty Box—Here’s Why It Matters
- Treasury Yields Are Surging Again: 3 Stocks That Could Feel the Pain
- Snowflake Could Be Headed for New Highs Despite Insider Selling
- MongoDB Is Surging—And the Next Catalyst Is Almost Here
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
